Our Team
Management
Dr. David Stover
Founder and CEO
Dr. Stover has over 25 years of experience in both small molecule and biologics drug discovery and development at Agensys/Astellas, Novartis, MDS Proteomics, Kinetix Pharmaceuticals, and Ciba-Geigy.
Dr. Stover is an accomplished drug developer having been directly involved in 15 INDs, 8 of which reached clinical Proof of Concept so far. He earned his Ph.D. in Biochemistry at the University of Washington and holds a B.S. in Zoology from Duke University.
Dr. Sherie Morrison
Senior Scientific Advisor
Distinguished UCLA Professor with over 30 patents for antibody engineering inventions. (Co-founder/President Qwixel Therapeutics)
Joseph Rice
EVP of Operations
Joseph (Joe) has executive leadership experience across a range of disciplines in financial services. In a 30 year career at Wells Fargo, he served as Chief Credit Officer and Chief Operational Risk Officer, and led several high-profile regulatory initiatives. He earned a B.S. in Civil Engineering at UCLA and an M.B.A. from UC Berkeley.
Board Members
Dr. David Stover
Dr. Stover has over 25 years of experience in both small molecule and biologics drug discovery and development at Agensys/Astellas, Novartis, MDS Proteomics, Kinetix Pharmaceuticals, and Ciba-Geigy.
Dr. Stover is an accomplished drug developer having been directly involved in 15 INDs, 8 of which reached clinical Proof of Concept so far. He earned his Ph.D. in Biochemistry at the University of Washington and holds a B.S. in Zoology from Duke University.
Donald B. Rice, Ph.D.
Co-founder, president & CEO of Agensys, Inc, cancer biotech, sold to Astellas Pharma; Chair of Board of Scios, Inc., cardio biotech, sold to Johnson & Johnson.
Retired director of Chevron, Wells Fargo, Amgen, and Vulcan Materials.
Former President & COO, Teledyne, Inc.; Secretary of the U. S. Air Force; President & CEO, The RAND Corporation.
PhD, Economics & MS, Industrial Management, Purdue University; BS Chem Engr, University of Notre Dame.
George Ayoub
Extensive executive leadership experience. (Co-founder/CEO of One Lambda and Qwixel Therapeutics)
Kenan Turnacioglu, Ph.D.
Chairperson at Paige, a machine learning pathology company. Board member at Immunai, biotech company. Co-founder PointState Capital LP, formerly served at Duquesne Capital Management LLC and Credit Suisse.
B.A. from Rutgers University, Ph.D. University of Pennsylvania.